A Nanoinhibitor Targeting cGAS-STING Pathway to Reverse the Homeostatic Imbalance of Inflammation in Psoriasis

Angew Chem Int Ed Engl. 2024 Jan 8;63(2):e202316007. doi: 10.1002/anie.202316007. Epub 2023 Dec 7.

Abstract

Psoriasis is a chronic skin inflammation characterized by dysregulated crosstalk between immune cells and keratinocytes. Here we show that the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is a key regulator of psoriatic inflammation in a mouse model. Platinum-doped positively charged carbon dots (Pt-CDs) were designed to inhibit the cGAS-STING pathway. By inhibiting the cGAS-STING pathway with Pt-CDs, the secretion of proinflammatory cytokines in macrophages was reduced, and the proinflammatory cytokines-induced breakdown of immunological tolerance and overexpression of chemokines in keratinocytes was restored, which reversed the homeostatic imbalance through breaking these cytokines-mediated intercellular positive feedback loop. Topical Pt-CDs treatment exhibited therapeutic effects in imiquimod-induced psoriasis mice without noticeable toxicity. The reversal of elevated expression of STING, phosphorylated STING, and downstream genes within psoriatic lesions indicates that Pt-CDs effectively inhibit the cGAS-STING pathway. This work suggests a promising strategy for psoriasis treatment by targeting the cGAS-STING pathway with Pt-CDs nanoinhibitor to restore skin homeostatic balance.

Keywords: Carbon Dots; Inflammation; Nanoinhibitor; Psoriasis; cGAS-STING Pathway.

MeSH terms

  • Animals
  • Cytokines / metabolism
  • Inflammation / drug therapy
  • Mice
  • Nucleotidyltransferases / metabolism
  • Psoriasis* / drug therapy
  • Signal Transduction*

Substances

  • Nucleotidyltransferases
  • Cytokines